TrialInvestigational new drugs2012
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma.
Andrew H Ko et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it